| Literature DB >> 20333321 |
Elizabeth R Rayburn1, Scharri J Ezell, Ruiwen Zhang.
Abstract
Inflammation is closely linked to cancer, and many anti-cancer agents are also used to treat inflammatory diseases, such as rheumatoid arthritis. Moreover, chronic inflammation increases the risk for various cancers, indicating that eliminating inflammation may represent a valid strategy for cancer prevention and therapy. This article explores the relationship between inflammation and cancer with an emphasis on epidemiological evidence, summarizes the current use of anti-inflammatory agents for cancer prevention and therapy, and describes the mechanisms underlying the anti-cancer effects of anti-inflammatory agents. Since monotherapy is generally insufficient for treating cancer, the combined use of anti-inflammatory agents and conventional cancer therapy is also a focal point in discussion. In addition, we also briefly describe future directions that should be explored for anti-cancer anti-inflammatory agents.Entities:
Year: 2009 PMID: 20333321 PMCID: PMC2843097 DOI: 10.4255/mcpharmacol.09.05
Source DB: PubMed Journal: Mol Cell Pharmacol ISSN: 1938-1247